William F. Herblin

Identification of angiotensin II receptor subtypes

Andrew T. Chiu, William F. Herblin, Dale E. McCall et al. · Biochemical and Biophysical Research Communications · 1989 · 822 citations

Hypertension, Molecular Physiology, Autoimmune Disease +6

Identification and concerted function of two receptor binding surfaces on basic fibroblast growth factor required for mitogenesis.

Barry A. Springer, Michael W. Pantoliano, Frank Barbera et al. · Journal of Biological Chemistry · 1994 · 141 citations · Full text

Cell Adhesion, Cell Proliferation, Cytoskeleton +20

Discrimination of angiotensin II receptor subtypes by dithiothreitol

Andrew T. Chiu, Dale E. McCall, Tâm Nguyễn et al. · European Journal of Pharmacology · 1989 · 134 citations

Hypertension, Functional Selectivity, Medicine +7

Suramin, an anticancer and angiosuppressive agent, inhibits endothelial cell binding of basic fibroblast growth factor, migration, proliferation, and induction of urokinase-type plasminogen activator.

Shingo Takano, Stephen Gately, Mary E. Neville et al. · PubMed · 1994 · 132 citations

Endothelial Cell Binding, Pathology, Pharmacotherapy +20

Effects of Modulation of Basic Fibroblast Growth Factor on Tumor Growth In Vivo

Janet L. Gross, William F. Herblin, Betsy A. Dusak et al. · JNCI Journal of the National Cancer Institute · 1993 · 105 citations